Enforcement Report - Week of May 15, 2024
15 May 2024 //
FDA
Enforcement Report - Week of December 7, 2022
07 Dec 2022 //
FDA
Enforcement Report - Week of November 30, 2022
30 Nov 2022 //
FDA
Enforcement Report - Week of June 2, 2021
02 Jun 2021 //
FDA
Acella, facing 43 `serious` side effect reports, pulls dozens of lots
04 May 2021 //
FIERCEPHARMA
Acella Issues Voluntary Nationwide Recall of Certain Lots of NP Thyroid®
29 Apr 2021 //
PRNEWSWIRE
Quality Lowdown: Warning Letters Suggest How FDA Set Priorities During COVID-19
09 Sep 2020 //
PINK SHEET
Acella Pharmaceuticals Receives FDA Warning Letter
02 Sep 2020 //
FDA
FDA warns Mylan, Acella Pharmaceuticals over GMP violations
01 Sep 2020 //
RAPS
Enforcement Report - Week of June 10, 2020
10 Jun 2020 //
FDA
Valeant Announces U.S. Launch of SILIQ™ (brodalumab) Injection
28 Jul 2017 //
PR NEWSWIRE
Acella Pharmaceuticals, LLC, announces approval of generic to Vituz®
27 Jul 2017 //
PR NEWSWIRE